Summaries & Associations of Study Results
TR-278 2,6-Xylidine
Target Organs and Levels of Evidence
NTP Technical Report Number 278
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| 2,6-XYLIDINE 87-62-7 |
09/22/82 | CHEMICAL INTERMEDIATE FOR DYES. (TDB) | Dosed-Feed 0,300,1000,3000 PPM/56 ANIMALS PER GROUP | Litton Bionetics, Inc. |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: POSITIVE | NASAL CAVITY: ADENOMA 0/56 0/56 2/56 10/56; CARCINOMA 0/56 0/56 0/56 26/56 | |||
| MAY HAVE BEEN RELATED: | SUBCUTANEOUS TISSUE: FIBROMA 0/56 1/56 2/56 4/56; FIBROSARCOMA 0/56 1/56 0/56 1/56 | |||
| FR: POSITIVE | NASAL CAVITY: ADENOMA 0/56 0/56 1/56 6/56; CARCINOMA 0/56 0/56 1/56 24/56 | |||
| MAY HAVE BEEN RELATED: | SUBCUTANEOUS TISSUE: FIBROMA 0/56 2/56 1/56 4/56; FIBROSARCOMA 1/56 0/56 1/56 3/56 | |||
| LIVER: NEOPLASTIC NODULE 0/56 1/56 2/56 4/56 | ||||
Web page last updated on February 10, 2006
